bacterin international holdi
(BONE:NYSE Amex)

Executive Profile*

Background*

Mr. John P. Gandolfo, CPA, has been the Chief Financial Officer of Bacterin International Holdings, Inc. since July 6, 2010, its Interim Co-Chief Executive Officer since April 5, 2013 and also serves as its Treasurer and Secretary. Mr. Gandolfo serves as the Chief Financial Officer of Amorcyte Inc., which has a strategic partnership with Progenitor Cell Therapy. Mr. Gandolfo served as the Interim Chief Financial Officer of Bacterin International Holdings, Inc. (AKA: ... Bacterin International, Inc) since June 30, 2010 and K-Kitz, Inc. until June 30, 2010. Prior to joining Bacterin, Mr. Gandolfo served as the Chief Financial Officer of Progenitor Cell Therapy, LLC since January 2009. He began his professional career at Price Waterhouse. He has over 21 years of experience as Chief Financial Officer of rapidly growing private and publicly held companies with a primary focus in the life sciences, healthcare and medical device sectors. He had direct responsibility over private and public capital raising, financial management, mergers and acquisition transactions and SEC reporting throughout his professional career. He has in-depth experience in corporate finance, M&A, treasury, SEC reporting, corporate operations and Sarbanes Oxley compliance. Mr. Gandolfo served as Chief Financial Officer of Power Medical Interventions, Inc. from January 2007 to December 26, 2008 and also served as its Principal Accounting Officer. Prior to joining Power Medical Interventions, he served as the Chief Financial Officer, Principal Accounting Officer and Vice President of Finance at Bioject Medical Technologies Inc., from September 2001 to May 2006 and was responsible for the successful licensing of its technology to various pharmaceutical companies. Prior to joining Bioject, he served as the Chief Financial Officer of Capital Access Network, Inc., from 2000 to September 2001. Mr. Gandolfo served as Senior Vice President and Chief Financial Officer of Worldwide Xceed Group, Inc. from November 12, 1999 to September 2000. Mr. Gandolfo served as the Chief Financial Officer and Chief Operating Officer of Impath Inc. from 1994 to 1999. Prior to joining Impath, Mr. Gandolfo served as the Chief Financial Officer of Medical Resources Inc. from 1987 to 1994. He served as a Director of Bioject Medical Technologies Inc. from September 2006 to May 2007. He is a Certified Public Accountant. Mr. Gandolfo holds a Bachelor of Arts degree in Business Administration from Rutgers University.

Report Data Issue

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Recently Viewed
BONE:US	$0.75 USD	-0.0303

COMPETITOR COMPENSATION